Why the study?
Does the ISCHEMIA trial affect the Appropriate Use Criteria ratings for percutaneous coronary intervention in patients with stable ischemic heart disease?
Does the ISCHEMIA trial affect the Appropriate Use Criteria ratings for percutaneous coronary intervention in patients with stable ischemic heart disease?
Answers are grounded in this paper and cite their sources.
This study evaluates how the ISCHEMIA trial findings might influence the Appropriate Use Criteria ratings for PCI in stable ischemic heart disease.
This cohort study examines the potential implications of the ISCHEMIA trial on the appropriateness of percutaneous coronary intervention in patients with stable ischemic heart disease.
No takes yet. Share an insight, caveat, or question.
Malik et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: